- Home
- ATCH vs BJDX Comparison
ATCH vs BJDX Comparison
Compare ATCH & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATCH
- BJDX
- Stock Information
- Founded
- ATCH 2022
- BJDX 2015
- Country
- ATCH United States
- BJDX United States
- Employees
- ATCH N/A
- BJDX N/A
- Industry
- ATCH
- BJDX Medical Specialities
- Sector
- ATCH
- BJDX Health Care
- Exchange
- ATCH Nasdaq
- BJDX Nasdaq
- Market Cap
- ATCH 3.0M
- BJDX 2.9M
- IPO Year
- ATCH N/A
- BJDX 2021
- Fundamental
- Price
- ATCH $0.19
- BJDX $1.58
- Analyst Decision
- ATCH
- BJDX
- Analyst Count
- ATCH 0
- BJDX 0
- Target Price
- ATCH N/A
- BJDX N/A
- AVG Volume (30 Days)
- ATCH 2.7M
- BJDX 2.1M
- Earning Date
- ATCH 05-16-2025
- BJDX 08-13-2025
- Dividend Yield
- ATCH N/A
- BJDX N/A
- EPS Growth
- ATCH N/A
- BJDX N/A
- EPS
- ATCH 2.67
- BJDX N/A
- Revenue
- ATCH N/A
- BJDX N/A
- Revenue This Year
- ATCH N/A
- BJDX N/A
- Revenue Next Year
- ATCH N/A
- BJDX $55.56
- P/E Ratio
- ATCH $0.07
- BJDX N/A
- Revenue Growth
- ATCH N/A
- BJDX N/A
- 52 Week Low
- ATCH $0.18
- BJDX $1.46
- 52 Week High
- ATCH $66.00
- BJDX $44.50
- Technical
- Relative Strength Index (RSI)
- ATCH 34.16
- BJDX 42.16
- Support Level
- ATCH $0.18
- BJDX $1.49
- Resistance Level
- ATCH $0.20
- BJDX $1.63
- Average True Range (ATR)
- ATCH 0.02
- BJDX 0.16
- MACD
- ATCH 0.01
- BJDX -0.00
- Stochastic Oscillator
- ATCH 10.53
- BJDX 7.29
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.